Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2018

Open Access 01-12-2018 | Research

The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy

Authors: Thanh Liem Nguyen, Hoang Phuong Nguyen, Trung Kien Nguyen

Published in: Health and Quality of Life Outcomes | Issue 1/2018

Login to get access

Abstract

Background

Quality of life (QOL) is an important factor in evaluating the effectiveness of treatment in children with cerebral palsy (CP). The aim of this study was to evaluate the effects of autologous bone marrow mononuclear cells (BM MNCs) on the QOL of children with CP.

Methods

From December 2015 to December 2016, 30 children with CP aged from 2 to 15 years received two intrathecal infusions of BM MNCs, one at baseline and the other 3 months later, at Vinmec International Hospital. The motor function and muscle tone of the patients were evaluated using the Gross Motor Function Measure (GMFM)-88 and Modified Ashworth Score, respectively. Their QOL was assessed at baseline and 6 months after the first BM MNC transplant using the Vietnamese version of the Cerebral Palsy Quality of Life Questionnaire for children (CP QOL-Child)–the parental proxy report, which comprises seven domains. Nineteen mothers (mean age: 32.9±4.9 years) and 11 fathers (mean age: 36.1±6.8 years) were invited to complete the CP QOL-Child assessment before and after the transplantations, Paired t-tests and multivariate regression analyses were used to evaluate the changes in QOL and GMFM scores and to identify the key factors correlated with the QOL score.

Results

Significant changes were observed in the children’s gross motor function and muscle spasticity, as evidenced by the GMFM-88 total score, scores for each of its domains, the GMFM-66 percentile and the muscle tone (P < 0.001). Six months after the transplantations, the QOL scores of children with CP were markedly increased (P < 0.001) for all the domains, except for the domain of access to services. In the multivariate regression analysis, significant associations were found between higher age of children and higher QOL except for feeling about functioning and pain and impact of disability domains. Gross Motor Function Classification System (GMFCS) level was negatively correlated with the score of pain and impact of disability domain, while the GMFM-88 scores were positively correlated with the QOL in terms of feelings about functioning and family health domain (P < 0.05).

Conclusion

The QOL of the children with CP was noticeably improved 6 months after BM MNC transplantation and was accompanied by improvements in gross motor function and muscle tone.

Trial registration

ClinicalTrials.​gov Identifier: NCT02574923. Registered on October 14, 2015.
Literature
6.
go back to reference Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: A systematic review and meta-analysis. Dev Med Child Neurol. 2013;55:509–19.CrossRefPubMed Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: A systematic review and meta-analysis. Dev Med Child Neurol. 2013;55:509–19.CrossRefPubMed
8.
go back to reference Singhi P, Saini AG. Changes in the clinical spectrum of cerebral palsy over two decades in North India-an analysis of 1212 cases. J Trop Pediatr. 2013;59(6):434–40.CrossRefPubMed Singhi P, Saini AG. Changes in the clinical spectrum of cerebral palsy over two decades in North India-an analysis of 1212 cases. J Trop Pediatr. 2013;59(6):434–40.CrossRefPubMed
10.
go back to reference Qu SQ, Luan Z, Yin GC, Guo WL, Hu XH, Wu NH, et al. Transplantation of human fetal neural stem cells into cerebral ventricle of the neonatal rat following hypoxic-ischemic injury: survival, migration and differentiation. Zhonghua Er Ke Za Zhi. 2005;43(8):576–9.PubMed Qu SQ, Luan Z, Yin GC, Guo WL, Hu XH, Wu NH, et al. Transplantation of human fetal neural stem cells into cerebral ventricle of the neonatal rat following hypoxic-ischemic injury: survival, migration and differentiation. Zhonghua Er Ke Za Zhi. 2005;43(8):576–9.PubMed
11.
go back to reference Workinger MS, Kent RD, Meilahn JR. The effect of botulinum toxin A (Botox) injections used to treat limb spasticity on speech patterns in children with dysarthria and cerebral palsy: A report of two cases. J Pediatr Rehabil Med. 2017;10(2):137–43.CrossRefPubMed Workinger MS, Kent RD, Meilahn JR. The effect of botulinum toxin A (Botox) injections used to treat limb spasticity on speech patterns in children with dysarthria and cerebral palsy: A report of two cases. J Pediatr Rehabil Med. 2017;10(2):137–43.CrossRefPubMed
13.
go back to reference Park E-Y, Kim W-H. Effect of neurodevelopmental treatment-based physical therapy on the change of muscle strength, spasticity, and gross motor function in children with spastic cerebral palsy. J Phys Ther Sci. 2017;29:966–9.CrossRefPubMedPubMedCentral Park E-Y, Kim W-H. Effect of neurodevelopmental treatment-based physical therapy on the change of muscle strength, spasticity, and gross motor function in children with spastic cerebral palsy. J Phys Ther Sci. 2017;29:966–9.CrossRefPubMedPubMedCentral
14.
go back to reference Abi Chahine NH, Wehbe TW, Hilal RA, Zoghbi VV, Melki AE, Bou Habib EB. Treatment of cerebral palsy with stem cells: A report of 17 Cases. Int J Stem Cells. 2016;9(1):90–5.CrossRefPubMedPubMedCentral Abi Chahine NH, Wehbe TW, Hilal RA, Zoghbi VV, Melki AE, Bou Habib EB. Treatment of cerebral palsy with stem cells: A report of 17 Cases. Int J Stem Cells. 2016;9(1):90–5.CrossRefPubMedPubMedCentral
15.
go back to reference Sharma A, Gokulchandran N, Chopra G, Kulkarni P, Lohia M, Badhe P, et al. Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplant. 2012;21(SUPPL. 1):S79–90.CrossRefPubMed Sharma A, Gokulchandran N, Chopra G, Kulkarni P, Lohia M, Badhe P, et al. Administration of autologous bone marrow-derived mononuclear cells in children with incurable neurological disorders and injury is safe and improves their quality of life. Cell Transplant. 2012;21(SUPPL. 1):S79–90.CrossRefPubMed
21.
go back to reference Davis E, Reddihough D, Murphy N, Epstein A, Reid SM, Whitehouse A, et al. Exploring quality of life of children with cerebral palsy and intellectual disability: What are the important domains of life? Child Care Health Dev. 2017;43(6):854–60.CrossRefPubMed Davis E, Reddihough D, Murphy N, Epstein A, Reid SM, Whitehouse A, et al. Exploring quality of life of children with cerebral palsy and intellectual disability: What are the important domains of life? Child Care Health Dev. 2017;43(6):854–60.CrossRefPubMed
25.
go back to reference Waters E, Davis E, Mackinnon A, Boyd R, Graham HK, Kai Lo S, et al. Psychometric properties of the quality of life questionnaire for children with CP. Dev Med Child Neurol. 2007;49(1):49–55.CrossRefPubMed Waters E, Davis E, Mackinnon A, Boyd R, Graham HK, Kai Lo S, et al. Psychometric properties of the quality of life questionnaire for children with CP. Dev Med Child Neurol. 2007;49(1):49–55.CrossRefPubMed
33.
go back to reference Pashmdarfard M, Amini M, Badv RS, Ghaffarzade Namazi N, Rassafiani M. Does Parent Report Gross Motor Function Level of Cerebral Palsy Children Impact on the Quality of Life in these Children? Iran J child Neurol. 2017;11(4):52–7.PubMedPubMedCentral Pashmdarfard M, Amini M, Badv RS, Ghaffarzade Namazi N, Rassafiani M. Does Parent Report Gross Motor Function Level of Cerebral Palsy Children Impact on the Quality of Life in these Children? Iran J child Neurol. 2017;11(4):52–7.PubMedPubMedCentral
Metadata
Title
The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy
Authors
Thanh Liem Nguyen
Hoang Phuong Nguyen
Trung Kien Nguyen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2018
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-018-0992-x

Other articles of this Issue 1/2018

Health and Quality of Life Outcomes 1/2018 Go to the issue